16hbe cell
Recently Published Documents


TOTAL DOCUMENTS

6
(FIVE YEARS 2)

H-INDEX

2
(FIVE YEARS 0)

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Panfeng Chen ◽  
Ping Jiang ◽  
Jianing Chen ◽  
Yang Yang ◽  
Xiumei Guo

Abstract Background Chronic obstructive pulmonary disease (COPD) is a disease that causes obstructed airways and abnormal inflammatory responses in the lungs. Early growth response 3 (EGR3) has been revealed to play a vital role in the regulation of the inflammatory response in certain diseases. We aimed to explore the role of EGR3 and its upstream mechanism in COPD. Methods and result In the present study, 16HBE cells were treated with cigarette smoke extract (CSE) to mimic the inflammatory response in vitro. RT-qPCR revealed that the expression of EGR3 was upregulated in lungs from COPD patients. EGR3 expression in 16HBE cells was increased by CSE treatment. Moreover, flow cytometry analysis and western blot analysis showed that EGR3 downregulation inhibited 16HBE cell apoptosis. EGR3 silencing decreased the protein levels of IL-6, TNF-α, IL-1β and COX2 in CSE-stimulated 16HBE cells. In addition, EGR3 was targeted by microRNA-200c-3p (miR-200c-3p) in 16HBE cells. MiR-200c-3p expression was significantly decreased in lung tissues from COPD patients compared to that in healthy controls. Furthermore, miR-200c-3p bound to lncRNA X-inactive specific transcript (XIST) in 16HBE cells. Additionally, XIST expression was elevated in lung tissues from COPD patients. Rescue assays indicated that EGR3 overexpression counteracted the effects of XIST downregulation on apoptosis and inflammation in CSE-stimulated 16HBE cells. Conclusion The XIST/miR-200c-3p/EGR3 axis facilitated apoptosis and inflammation in CSE-stimulated 16HBE cells. These findings may provide novel insight for treating COPD by alleviating lung inflammation.


Metabolites ◽  
2020 ◽  
Vol 10 (3) ◽  
pp. 113 ◽  
Author(s):  
Daniel Schultz ◽  
Surabhi Surabhi ◽  
Nicolas Stelling ◽  
Michael Rothe ◽  
Karen Methling ◽  
...  

Respiratory tract infections are a global health problem. The main causative agents of these infections are influenza A virus (IAV), Staphylococcus aureus (S. aureus), and Streptococcus pneumoniae (S. pneumoniae). Major research focuses on genetics and immune responses in these infections. Eicosanoids and other oxylipins are host-derived lipid mediators that play an important role in the activation and resolution of inflammation. In this study, we assess, for the first time, the different intracellular profiles of these bioactive lipid mediators during S. aureus LUG2012, S. pneumoniae TIGR4, IAV, and corresponding viral and bacterial co-infections of 16HBE cells. We observed a multitude of altered lipid mediators. Changes in the amount of 5-hydroxyeicosatetraenoic acid (5-HETE) were prominent for all bacterial infections. The infection with S. pneumoniae showed the strongest impact on bioactive lipid production and led to alterations in the amount of PPARγ ligands and precursors of pro-resolving lipid mediators.


Inflammation ◽  
2019 ◽  
Vol 42 (2) ◽  
pp. 471-484 ◽  
Author(s):  
Jiexiong Yao ◽  
Jihua Zhang ◽  
Wenlin Tai ◽  
Shuhao Deng ◽  
Ting Li ◽  
...  

Toxicology ◽  
2016 ◽  
Vol 344-346 ◽  
pp. 1-6 ◽  
Author(s):  
Yang Li ◽  
Guiping Hu ◽  
Ping Li ◽  
Shichuan Tang ◽  
Ji Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document